SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1EU'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1AJ6_A_NOVA1_1 (GYRASE)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	8 / 9	ASN A 42 GLU A 46 ASP A 69 ARG A 72 PRO A 75 ALA A 86 ILE A 90 THR A 163	1EU A 2 (-4.9A) 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.2A) None 1EU A 2 (-4.5A) 1EU A 2 (-3.7A)	0.69A	1aj6A-3fv5A: 26.7	1aj6A-3fv5A: 47.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	8 / 12	ASP A 45 GLU A 46 ASP A 69 ARG A 72 PRO A 75 ILE A 90 ARG A 132 THR A 163	None 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.2A) 1EU A 2 (-4.5A) 1EU A 2 (-3.9A) 1EU A 2 (-3.7A)	0.56A	1kijA-3fv5A: 27.2	1kijA-3fv5A: 29.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	8 / 12	GLU A 46 ASP A 69 ARG A 72 PRO A 75 ASP A 77 ILE A 90 ARG A 132 THR A 163	1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.2A) None 1EU A 2 (-4.5A) 1EU A 2 (-3.9A) 1EU A 2 (-3.7A)	0.95A	1kijA-3fv5A: 27.2	1kijA-3fv5A: 29.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	9 / 12	ASN A 42 GLU A 46 ASP A 69 ARG A 72 PRO A 75 ASP A 77 ILE A 90 ARG A 132 THR A 163	1EU A 2 (-4.9A) 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.2A) None 1EU A 2 (-4.5A) 1EU A 2 (-3.9A) 1EU A 2 (-3.7A)	0.91A	1kijB-3fv5A: 27.6	1kijB-3fv5A: 29.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1S14_A_NOVA1300_1 (TOPOISOMERASE IV SUBUNIT B)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	11 / 12	ASN A 42 SER A 43 ASP A 45 GLU A 46 ASP A 69 ARG A 72 MET A 74 PRO A 75 ILE A 90 ARG A 132 THR A 163	1EU A 2 (-4.9A) 1EU A 2 (-3.0A) None 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.4A) 1EU A 2 (-4.2A) 1EU A 2 (-4.5A) 1EU A 2 (-3.9A) 1EU A 2 (-3.7A)	0.38A	1s14A-3fv5A: 29.5	1s14A-3fv5A: 88.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1S14_A_NOVA1300_1 (TOPOISOMERASE IV SUBUNIT B)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	11 / 12	ASN A 42 SER A 43 GLU A 46 ASP A 69 ARG A 72 MET A 74 PRO A 75 ASP A 77 ILE A 90 ARG A 132 THR A 163	1EU A 2 (-4.9A) 1EU A 2 (-3.0A) 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.4A) 1EU A 2 (-4.2A) None 1EU A 2 (-4.5A) 1EU A 2 (-3.9A) 1EU A 2 (-3.7A)	0.72A	1s14A-3fv5A: 29.5	1s14A-3fv5A: 88.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	11 / 12	ASN A 42 SER A 43 ASP A 45 GLU A 46 ASP A 69 ARG A 72 MET A 74 PRO A 75 ALA A 86 ILE A 90 ARG A 132	1EU A 2 (-4.9A) 1EU A 2 (-3.0A) None 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.4A) 1EU A 2 (-4.2A) None 1EU A 2 (-4.5A) 1EU A 2 (-3.9A)	0.45A	1s14B-3fv5A: 32.1	1s14B-3fv5A: 88.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	11 / 12	ASN A 42 SER A 43 ASP A 45 GLU A 46 ASP A 69 ARG A 72 MET A 74 PRO A 75 ASP A 77 ILE A 90 ARG A 132	1EU A 2 (-4.9A) 1EU A 2 (-3.0A) None 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.4A) 1EU A 2 (-4.2A) None 1EU A 2 (-4.5A) 1EU A 2 (-3.9A)	0.77A	1s14B-3fv5A: 32.1	1s14B-3fv5A: 88.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LPS_A_NOVA901_1 (TOPOISOMERASE IV SUBUNIT B)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	11 / 12	ASN A 42 SER A 43 ASP A 45 GLU A 46 ASP A 69 ARG A 72 MET A 74 PRO A 75 ILE A 90 ARG A 132 THR A 163	1EU A 2 (-4.9A) 1EU A 2 (-3.0A) None 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.4A) 1EU A 2 (-4.2A) 1EU A 2 (-4.5A) 1EU A 2 (-3.9A) 1EU A 2 (-3.7A)	0.54A	3lpsA-3fv5A: 31.0	3lpsA-3fv5A: 40.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LPS_A_NOVA901_1 (TOPOISOMERASE IV SUBUNIT B)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	9 / 12	SER A 43 GLU A 46 ASP A 69 ARG A 72 MET A 74 PRO A 75 ASP A 77 ARG A 132 THR A 163	1EU A 2 (-3.0A) 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.4A) 1EU A 2 (-4.2A) None 1EU A 2 (-3.9A) 1EU A 2 (-3.7A)	1.01A	3lpsA-3fv5A: 31.0	3lpsA-3fv5A: 40.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URN_A_NOVA2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	9 / 11	ASN A 42 SER A 43 ASP A 45 GLU A 46 ASP A 69 ARG A 72 ILE A 90 ARG A 132 THR A 163	1EU A 2 (-4.9A) 1EU A 2 (-3.0A) None 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.5A) 1EU A 2 (-3.9A) 1EU A 2 (-3.7A)	0.81A	4urnA-3fv5A: 28.1	4urnA-3fv5A: 45.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URN_A_NOVA2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	10 / 11	ASN A 42 SER A 43 ASP A 45 GLU A 46 ASP A 69 ARG A 72 MET A 74 PRO A 75 ARG A 132 THR A 163	1EU A 2 (-4.9A) 1EU A 2 (-3.0A) None 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.4A) 1EU A 2 (-4.2A) 1EU A 2 (-3.9A) 1EU A 2 (-3.7A)	0.66A	4urnA-3fv5A: 28.1	4urnA-3fv5A: 45.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URN_A_NOVA2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	5 / 11	ASP A 45 GLU A 46 ASP A 69 ILE A 116 THR A 163	None 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) None 1EU A 2 (-3.7A)	1.31A	4urnA-3fv5A: 28.1	4urnA-3fv5A: 45.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URN_B_NOVB2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	10 / 11	ASN A 42 SER A 43 ASP A 45 GLU A 46 ASP A 69 ARG A 72 MET A 74 PRO A 75 ARG A 132 THR A 163	1EU A 2 (-4.9A) 1EU A 2 (-3.0A) None 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.4A) 1EU A 2 (-4.2A) 1EU A 2 (-3.9A) 1EU A 2 (-3.7A)	0.57A	4urnB-3fv5A: 26.5	4urnB-3fv5A: 45.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URN_B_NOVB2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	10 / 11	ASN A 42 SER A 43 ASP A 45 GLU A 46 ASP A 69 ARG A 72 PRO A 75 ILE A 90 ARG A 132 THR A 163	1EU A 2 (-4.9A) 1EU A 2 (-3.0A) None 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.2A) 1EU A 2 (-4.5A) 1EU A 2 (-3.9A) 1EU A 2 (-3.7A)	0.69A	4urnB-3fv5A: 26.5	4urnB-3fv5A: 45.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URN_B_NOVB2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	5 / 11	ASP A 45 GLU A 46 ASP A 69 ILE A 116 THR A 163	None 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) None 1EU A 2 (-3.7A)	1.44A	4urnB-3fv5A: 26.5	4urnB-3fv5A: 45.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URN_C_NOVC2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	11 / 11	ASN A 42 SER A 43 ASP A 45 GLU A 46 ASP A 69 ARG A 72 MET A 74 PRO A 75 ILE A 90 ARG A 132 THR A 163	1EU A 2 (-4.9A) 1EU A 2 (-3.0A) None 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.4A) 1EU A 2 (-4.2A) 1EU A 2 (-4.5A) 1EU A 2 (-3.9A) 1EU A 2 (-3.7A)	0.64A	4urnC-3fv5A: 28.5	4urnC-3fv5A: 45.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URN_C_NOVC2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	5 / 11	ASP A 45 GLU A 46 ASP A 69 ILE A 116 THR A 163	None 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) None 1EU A 2 (-3.7A)	1.42A	4urnC-3fv5A: 28.5	4urnC-3fv5A: 45.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	8 / 12	ASN A 42 SER A 43 GLU A 46 ASP A 69 ARG A 72 PRO A 75 ASP A 77 ARG A 132	1EU A 2 (-4.9A) 1EU A 2 (-3.0A) 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.2A) None 1EU A 2 (-3.9A)	1.05A	4uroA-3fv5A: 28.0	4uroA-3fv5A: 46.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	8 / 12	ASN A 42 SER A 43 GLU A 46 ASP A 69 ARG A 72 PRO A 75 ILE A 90 ARG A 132	1EU A 2 (-4.9A) 1EU A 2 (-3.0A) 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.2A) 1EU A 2 (-4.5A) 1EU A 2 (-3.9A)	0.69A	4uroA-3fv5A: 28.0	4uroA-3fv5A: 46.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	8 / 12	ASN A 42 SER A 43 GLU A 46 ASP A 69 ARG A 72 PRO A 75 ASP A 77 ARG A 132	1EU A 2 (-4.9A) 1EU A 2 (-3.0A) 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.2A) None 1EU A 2 (-3.9A)	1.03A	4uroB-3fv5A: 28.3	4uroB-3fv5A: 46.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	8 / 12	ASN A 42 SER A 43 GLU A 46 ASP A 69 ARG A 72 PRO A 75 ILE A 90 ARG A 132	1EU A 2 (-4.9A) 1EU A 2 (-3.0A) 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.2A) 1EU A 2 (-4.5A) 1EU A 2 (-3.9A)	0.64A	4uroB-3fv5A: 28.3	4uroB-3fv5A: 46.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	8 / 12	ASN A 42 GLU A 46 ASP A 69 ARG A 72 PRO A 75 ALA A 86 ILE A 90 ARG A 132	1EU A 2 (-4.9A) 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.2A) None 1EU A 2 (-4.5A) 1EU A 2 (-3.9A)	0.63A	4uroC-3fv5A: 28.5	4uroC-3fv5A: 46.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	7 / 12	ASN A 42 GLU A 46 ASP A 69 ARG A 72 PRO A 75 ASP A 77 ARG A 132	1EU A 2 (-4.9A) 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.2A) None 1EU A 2 (-3.9A)	1.16A	4uroC-3fv5A: 28.5	4uroC-3fv5A: 46.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	9 / 12	ASN A 42 SER A 43 GLU A 46 ASP A 69 ARG A 72 PRO A 75 ILE A 90 ARG A 132 THR A 163	1EU A 2 (-4.9A) 1EU A 2 (-3.0A) 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.2A) 1EU A 2 (-4.5A) 1EU A 2 (-3.9A) 1EU A 2 (-3.7A)	0.62A	4uroD-3fv5A: 27.8	4uroD-3fv5A: 46.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	8 / 12	SER A 43 GLU A 46 ASP A 69 ARG A 72 PRO A 75 ASP A 77 ARG A 132 THR A 163	1EU A 2 (-3.0A) 1EU A 2 (-3.4A) 1EU A 2 (-3.3A) 1EU A 2 (-3.3A) 1EU A 2 (-4.2A) None 1EU A 2 (-3.9A) 1EU A 2 (-3.7A)	0.97A	4uroD-3fv5A: 27.8	4uroD-3fv5A: 46.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NY7_A_NCAA303_0 (AMIDASE)	3fv5	DNA TOPOISOMERASE 4 SUBUNIT B (Escherichia coli)	4 / 6	ARG A 72 PRO A 75 THR A 163 GLU A 46	1EU A 2 (-3.3A) 1EU A 2 (-4.2A) 1EU A 2 (-3.7A) 1EU A 2 (-3.4A)	1.07A	5ny7A-3fv5A: 2.0	5ny7A-3fv5A: 20.73

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1AJ6_A_NOVA1_1","GYRASE","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",8,"ASN A  42;GLU A  46;ASP A  69;ARG A  72;PRO A  75;ALA A  86;ILE A  90;THR A 163","1EU A   2 (-4.9A);1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.2A);None;1EU A   2 (-4.5A);1EU A   2 (-3.7A)","0.69A","1aj6A-3fv5A:26.7",null],["1KIJ_A_NOVA400_1","DNA GYRASE SUBUNIT B","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",8,"ASP A  45;GLU A  46;ASP A  69;ARG A  72;PRO A  75;ILE A  90;ARG A 132;THR A 163","None;1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.2A);1EU A   2 (-4.5A);1EU A   2 (-3.9A);1EU A   2 (-3.7A)","0.56A","1kijA-3fv5A:27.2","1aj6A-3fv5A:47.57"],["1KIJ_A_NOVA400_1","DNA GYRASE SUBUNIT B","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",8,"GLU A  46;ASP A  69;ARG A  72;PRO A  75;ASP A  77;ILE A  90;ARG A 132;THR A 163","1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.2A);None;1EU A   2 (-4.5A);1EU A   2 (-3.9A);1EU A   2 (-3.7A)","0.95A","1kijA-3fv5A:27.2","1kijA-3fv5A:29.37"],["1KIJ_B_NOVB444_1","DNA GYRASE SUBUNIT B","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",9,"ASN A  42;GLU A  46;ASP A  69;ARG A  72;PRO A  75;ASP A  77;ILE A  90;ARG A 132;THR A 163","1EU A   2 (-4.9A);1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.2A);None;1EU A   2 (-4.5A);1EU A   2 (-3.9A);1EU A   2 (-3.7A)","0.91A","1kijB-3fv5A:27.6","1kijA-3fv5A:29.37"],["1S14_A_NOVA1300_1","TOPOISOMERASE IV SUBUNIT B","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",11,"ASN A  42;SER A  43;ASP A  45;GLU A  46;ASP A  69;ARG A  72;MET A  74;PRO A  75;ILE A  90;ARG A 132;THR A 163","1EU A   2 (-4.9A);1EU A   2 (-3.0A);None;1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.4A);1EU A   2 (-4.2A);1EU A   2 (-4.5A);1EU A   2 (-3.9A);1EU A   2 (-3.7A)","0.38A","1s14A-3fv5A:29.5","1kijB-3fv5A:29.37"],["1S14_A_NOVA1300_1","TOPOISOMERASE IV SUBUNIT B","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",11,"ASN A  42;SER A  43;GLU A  46;ASP A  69;ARG A  72;MET A  74;PRO A  75;ASP A  77;ILE A  90;ARG A 132;THR A 163","1EU A   2 (-4.9A);1EU A   2 (-3.0A);1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.4A);1EU A   2 (-4.2A);None;1EU A   2 (-4.5A);1EU A   2 (-3.9A);1EU A   2 (-3.7A)","0.72A","1s14A-3fv5A:29.5","1s14A-3fv5A:88.56"],["1S14_B_NOVB2300_1","TOPOISOMERASE IV SUBUNIT B","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",11,"ASN A  42;SER A  43;ASP A  45;GLU A  46;ASP A  69;ARG A  72;MET A  74;PRO A  75;ALA A  86;ILE A  90;ARG A 132","1EU A   2 (-4.9A);1EU A   2 (-3.0A);None;1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.4A);1EU A   2 (-4.2A);None;1EU A   2 (-4.5A);1EU A   2 (-3.9A)","0.45A","1s14B-3fv5A:32.1","1s14A-3fv5A:88.56"],["1S14_B_NOVB2300_1","TOPOISOMERASE IV SUBUNIT B","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",11,"ASN A  42;SER A  43;ASP A  45;GLU A  46;ASP A  69;ARG A  72;MET A  74;PRO A  75;ASP A  77;ILE A  90;ARG A 132","1EU A   2 (-4.9A);1EU A   2 (-3.0A);None;1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.4A);1EU A   2 (-4.2A);None;1EU A   2 (-4.5A);1EU A   2 (-3.9A)","0.77A","1s14B-3fv5A:32.1","1s14B-3fv5A:88.56"],["3LPS_A_NOVA901_1","TOPOISOMERASE IV SUBUNIT B","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",11,"ASN A  42;SER A  43;ASP A  45;GLU A  46;ASP A  69;ARG A  72;MET A  74;PRO A  75;ILE A  90;ARG A 132;THR A 163","1EU A   2 (-4.9A);1EU A   2 (-3.0A);None;1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.4A);1EU A   2 (-4.2A);1EU A   2 (-4.5A);1EU A   2 (-3.9A);1EU A   2 (-3.7A)","0.54A","3lpsA-3fv5A:31.0","1s14B-3fv5A:88.56"],["3LPS_A_NOVA901_1","TOPOISOMERASE IV SUBUNIT B","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",9,"SER A  43;GLU A  46;ASP A  69;ARG A  72;MET A  74;PRO A  75;ASP A  77;ARG A 132;THR A 163","1EU A   2 (-3.0A);1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.4A);1EU A   2 (-4.2A);None;1EU A   2 (-3.9A);1EU A   2 (-3.7A)","1.01A","3lpsA-3fv5A:31.0","3lpsA-3fv5A:40.35"],["4URN_A_NOVA2000_1","DNA TOPOISOMERASE IV, B SUBUNIT","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",9,"ASN A  42;SER A  43;ASP A  45;GLU A  46;ASP A  69;ARG A  72;ILE A  90;ARG A 132;THR A 163","1EU A   2 (-4.9A);1EU A   2 (-3.0A);None;1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.5A);1EU A   2 (-3.9A);1EU A   2 (-3.7A)","0.81A","4urnA-3fv5A:28.1","3lpsA-3fv5A:40.35"],["4URN_A_NOVA2000_1","DNA TOPOISOMERASE IV, B SUBUNIT","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",10,"ASN A  42;SER A  43;ASP A  45;GLU A  46;ASP A  69;ARG A  72;MET A  74;PRO A  75;ARG A 132;THR A 163","1EU A   2 (-4.9A);1EU A   2 (-3.0A);None;1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.4A);1EU A   2 (-4.2A);1EU A   2 (-3.9A);1EU A   2 (-3.7A)","0.66A","4urnA-3fv5A:28.1","4urnA-3fv5A:45.85"],["4URN_A_NOVA2000_1","DNA TOPOISOMERASE IV, B SUBUNIT","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",5,"ASP A  45;GLU A  46;ASP A  69;ILE A 116;THR A 163","None;1EU A   2 (-3.4A);1EU A   2 (-3.3A);None;1EU A   2 (-3.7A)","1.31A","4urnA-3fv5A:28.1","4urnA-3fv5A:45.85"],["4URN_B_NOVB2000_1","DNA TOPOISOMERASE IV, B SUBUNIT","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",10,"ASN A  42;SER A  43;ASP A  45;GLU A  46;ASP A  69;ARG A  72;MET A  74;PRO A  75;ARG A 132;THR A 163","1EU A   2 (-4.9A);1EU A   2 (-3.0A);None;1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.4A);1EU A   2 (-4.2A);1EU A   2 (-3.9A);1EU A   2 (-3.7A)","0.57A","4urnB-3fv5A:26.5","4urnA-3fv5A:45.85"],["4URN_B_NOVB2000_1","DNA TOPOISOMERASE IV, B SUBUNIT","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",10,"ASN A  42;SER A  43;ASP A  45;GLU A  46;ASP A  69;ARG A  72;PRO A  75;ILE A  90;ARG A 132;THR A 163","1EU A   2 (-4.9A);1EU A   2 (-3.0A);None;1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.2A);1EU A   2 (-4.5A);1EU A   2 (-3.9A);1EU A   2 (-3.7A)","0.69A","4urnB-3fv5A:26.5","4urnB-3fv5A:45.85"],["4URN_B_NOVB2000_1","DNA TOPOISOMERASE IV, B SUBUNIT","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",5,"ASP A  45;GLU A  46;ASP A  69;ILE A 116;THR A 163","None;1EU A   2 (-3.4A);1EU A   2 (-3.3A);None;1EU A   2 (-3.7A)","1.44A","4urnB-3fv5A:26.5","4urnB-3fv5A:45.85"],["4URN_C_NOVC2000_1","DNA TOPOISOMERASE IV, B SUBUNIT","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",11,"ASN A  42;SER A  43;ASP A  45;GLU A  46;ASP A  69;ARG A  72;MET A  74;PRO A  75;ILE A  90;ARG A 132;THR A 163","1EU A   2 (-4.9A);1EU A   2 (-3.0A);None;1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.4A);1EU A   2 (-4.2A);1EU A   2 (-4.5A);1EU A   2 (-3.9A);1EU A   2 (-3.7A)","0.64A","4urnC-3fv5A:28.5","4urnB-3fv5A:45.85"],["4URN_C_NOVC2000_1","DNA TOPOISOMERASE IV, B SUBUNIT","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",5,"ASP A  45;GLU A  46;ASP A  69;ILE A 116;THR A 163","None;1EU A   2 (-3.4A);1EU A   2 (-3.3A);None;1EU A   2 (-3.7A)","1.42A","4urnC-3fv5A:28.5","4urnC-3fv5A:45.85"],["4URO_A_NOVA2000_1","DNA GYRASE SUBUNIT B","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",8,"ASN A  42;SER A  43;GLU A  46;ASP A  69;ARG A  72;PRO A  75;ASP A  77;ARG A 132","1EU A   2 (-4.9A);1EU A   2 (-3.0A);1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.2A);None;1EU A   2 (-3.9A)","1.05A","4uroA-3fv5A:28.0","4urnC-3fv5A:45.85"],["4URO_A_NOVA2000_1","DNA GYRASE SUBUNIT B","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",8,"ASN A  42;SER A  43;GLU A  46;ASP A  69;ARG A  72;PRO A  75;ILE A  90;ARG A 132","1EU A   2 (-4.9A);1EU A   2 (-3.0A);1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.2A);1EU A   2 (-4.5A);1EU A   2 (-3.9A)","0.69A","4uroA-3fv5A:28.0","4uroA-3fv5A:46.15"],["4URO_B_NOVB2000_1","DNA GYRASE SUBUNIT B","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",8,"ASN A  42;SER A  43;GLU A  46;ASP A  69;ARG A  72;PRO A  75;ASP A  77;ARG A 132","1EU A   2 (-4.9A);1EU A   2 (-3.0A);1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.2A);None;1EU A   2 (-3.9A)","1.03A","4uroB-3fv5A:28.3","4uroA-3fv5A:46.15"],["4URO_B_NOVB2000_1","DNA GYRASE SUBUNIT B","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",8,"ASN A  42;SER A  43;GLU A  46;ASP A  69;ARG A  72;PRO A  75;ILE A  90;ARG A 132","1EU A   2 (-4.9A);1EU A   2 (-3.0A);1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.2A);1EU A   2 (-4.5A);1EU A   2 (-3.9A)","0.64A","4uroB-3fv5A:28.3","4uroB-3fv5A:46.15"],["4URO_C_NOVC2000_1","DNA GYRASE SUBUNIT B","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",8,"ASN A  42;GLU A  46;ASP A  69;ARG A  72;PRO A  75;ALA A  86;ILE A  90;ARG A 132","1EU A   2 (-4.9A);1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.2A);None;1EU A   2 (-4.5A);1EU A   2 (-3.9A)","0.63A","4uroC-3fv5A:28.5","4uroB-3fv5A:46.15"],["4URO_C_NOVC2000_1","DNA GYRASE SUBUNIT B","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",7,"ASN A  42;GLU A  46;ASP A  69;ARG A  72;PRO A  75;ASP A  77;ARG A 132","1EU A   2 (-4.9A);1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.2A);None;1EU A   2 (-3.9A)","1.16A","4uroC-3fv5A:28.5","4uroC-3fv5A:46.15"],["4URO_D_NOVD2000_1","DNA GYRASE SUBUNIT B","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",9,"ASN A  42;SER A  43;GLU A  46;ASP A  69;ARG A  72;PRO A  75;ILE A  90;ARG A 132;THR A 163","1EU A   2 (-4.9A);1EU A   2 (-3.0A);1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.2A);1EU A   2 (-4.5A);1EU A   2 (-3.9A);1EU A   2 (-3.7A)","0.62A","4uroD-3fv5A:27.8","4uroC-3fv5A:46.15"],["4URO_D_NOVD2000_1","DNA GYRASE SUBUNIT B","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",8,"SER A  43;GLU A  46;ASP A  69;ARG A  72;PRO A  75;ASP A  77;ARG A 132;THR A 163","1EU A   2 (-3.0A);1EU A   2 (-3.4A);1EU A   2 (-3.3A);1EU A   2 (-3.3A);1EU A   2 (-4.2A);None;1EU A   2 (-3.9A);1EU A   2 (-3.7A)","0.97A","4uroD-3fv5A:27.8","4uroD-3fv5A:46.15"],["5NY7_A_NCAA303_0","AMIDASE","3fv5","DNA TOPOISOMERASE 4 SUBUNIT B","Escherichia coli",4,"ARG A  72;PRO A  75;THR A 163;GLU A  46","1EU A   2 (-3.3A);1EU A   2 (-4.2A);1EU A   2 (-3.7A);1EU A   2 (-3.4A)","1.07A","5ny7A-3fv5A:2.0","4uroD-3fv5A:46.15"]]